PANews reported on January 18 that, according to Sina Finance, Elon Musk filed a lawsuit with the court on Friday, seeking up to $134 billion in damages from artificialPANews reported on January 18 that, according to Sina Finance, Elon Musk filed a lawsuit with the court on Friday, seeking up to $134 billion in damages from artificial

Musk is suing OpenAI and Microsoft for up to $134 billion, alleging they "illicitly profited."

2026/01/18 16:59

PANews reported on January 18 that, according to Sina Finance, Elon Musk filed a lawsuit with the court on Friday, seeking up to $134 billion in damages from artificial intelligence startup OpenAI and its shareholder Microsoft , arguing that he should receive "unjust enrichment" for his early support of the company.

According to documents filed by Musk, he invested approximately $38 million, representing 60% of OpenAI's initial seed funding. He also assisted in recruiting employees, helped the founders connect with key figures, and added credibility to the project in its early stages. Musk stated in the documents, "Just as someone who invests early in a startup can reap returns several orders of magnitude higher than their initial investment, the improper gains that OpenAI and Microsoft have received (and Musk is now entitled to reclaim) far exceed his initial investment."

Market Opportunity
Startup Logo
Startup Price(STARTUP)
$0.0003427
$0.0003427$0.0003427
-4.30%
USD
Startup (STARTUP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.